Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study
Completed · Not applicable
Conditions studied: Atherosclerosis
In brief
The study will evaluate the clinical utilization of skin Cholesterol (SC) for cardiovascular risk assessment in asymptomatic individuals at low, intermediate and high risk based on Framingham global risk estimates. Preliminary studies have suggested that SC is an easy to measure, noninvasive marker of cardiovascular risk. This study is intended to provide further data in support of broader clearance by the Food and Drug Administration for the use of SC as a tool to identify asymptomatic patients at increased risk of cardiovascular disease. Currently, SC testing is cleared for use as part of risk assessment in subject suspected of having significant multi-vessel disease. The current study data will be used to support the use of SC testing as part of cardiovascular risk assessment in subjects without suspected coronary artery disease (CAD).
Key facts
- Study ID
- NCT00258999
- Run by
- University of Wisconsin, Madison
- People needed
- 600
- Starts
- 2005-10-01
- Expected to finish
- 2007-11-01
- Last updated by the study team
- 2015-10-05
Who can join
Age: 30 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Informed written consent from the subject prior to testing.
- Males or females 30-80 years of age
You may not qualify if…
- 1. Known coronary heart disease, (history of myocardial infarction, coronary bypass surgery, coronary angioplasty, or angina pectoris with a positive stress test or angiographic documentation)
- Known peripheral vascular disease (claudication with ankle-brachial index < 0.9, angioplasty, or peripheral artery bypass procedure)
- Known cerebrovascular disease (stroke or TIA with documented carotid or aortic atherosclerosis)
- History of carotid artery endarterectomy or carotid artery surgery
- Diabetes mellitus (fasting glucose > 126 mg/dL, on on insulin-reducing medications)
- 10-year Framingham risk of cardiac death or MI using ATP III calculator >20%
- Subjects taking cholesterol-lowering medications
- Known hepatitis
- Known pregnancy
- Skin disease on either hand (e.g. eczema psoriasis, rash or broken skin)
Where it is running
- University of Wisconsin — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.